![Figure 1 from Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy. | Semantic Scholar Figure 1 from Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/df88149ab3688401a9aaf108442bed7c0775e397/2-Figure1-1.png)
Figure 1 from Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy. | Semantic Scholar
![Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention | Future Cardiology Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca.09.1/asset/images/medium/graphic1.gif)
Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention | Future Cardiology
![Ticagrelor: Positive, negative and misunderstood properties as a new antiplatelet agent - Steiner - 2013 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library Ticagrelor: Positive, negative and misunderstood properties as a new antiplatelet agent - Steiner - 2013 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d6936bf9-28b5-4f03-8249-5f60ed822079/cep12097-fig-0001-m.jpg)
Ticagrelor: Positive, negative and misunderstood properties as a new antiplatelet agent - Steiner - 2013 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
![JCM | Free Full-Text | Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor | HTML JCM | Free Full-Text | Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor | HTML](https://www.mdpi.com/jcm/jcm-11-01124/article_deploy/html/images/jcm-11-01124-g001-550.jpg)
JCM | Free Full-Text | Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor | HTML
![Figure 1 from Ticagrelor--is there need for a new player in the antiplatelet-therapy field? | Semantic Scholar Figure 1 from Ticagrelor--is there need for a new player in the antiplatelet-therapy field? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6b86b12500876ada0a84cec01635e73e5fd9ac06/2-Figure1-1.png)
Figure 1 from Ticagrelor--is there need for a new player in the antiplatelet-therapy field? | Semantic Scholar
البورد العراقي للصيدلة السريرية - 🔺️P2Y12 receptor antagonists ➡️Ticlopidine, clopidogrel, prasugrel, ticagrelor and cangrelor are P2Y12 ADP receptor inhibitors that also block platelet aggregation but by a mechanism different from that of
![Bioactivation and mechanism of action of clopidogrel, prasugrel, and... | Download Scientific Diagram Bioactivation and mechanism of action of clopidogrel, prasugrel, and... | Download Scientific Diagram](https://www.researchgate.net/profile/Larisa-Cavallari/publication/233888670/figure/fig1/AS:202528286351360@1425297914100/Bioactivation-and-mechanism-of-action-of-clopidogrel-prasugrel-and-ticagrelor-CYP2C19.png)
Bioactivation and mechanism of action of clopidogrel, prasugrel, and... | Download Scientific Diagram
![An overview of the mechanism of action of antiplatelet drugs, showing... | Download Scientific Diagram An overview of the mechanism of action of antiplatelet drugs, showing... | Download Scientific Diagram](https://www.researchgate.net/profile/Guramrinder-Thind/publication/267753112/figure/fig1/AS:601627455148038@1520450571071/An-overview-of-the-mechanism-of-action-of-antiplatelet-drugs-showing-their-effects-on.png)